Gsk (GSK) Enterprise Value (2009 - 2026)
Gsk (GSK) posted Enterprise Value of $104.74 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Enterprise Value (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk's Enterprise Value came in at $100.62 billion, up 49.9% from the prior year.
- Annual Enterprise Value shows a five-year compound annual growth rate of 5.0% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Enterprise Value was $67.12 billion in the year ended Dec 31, 2024 (-11.0%), $75.4 billion in the year ended Dec 31, 2023 (+7.0%), $70.44 billion in the year ended Dec 31, 2022 (-27.8%) and $97.54 billion in the year ended Dec 31, 2021 (+23.5%).
- Quarterly Enterprise Value has run from a low of $58.4 billion in the quarter ended Sep 30, 2022 to a high of $113.75 billion in the quarter ended Mar 31, 2026 over five years.
- On a year-over-year basis, Enterprise Value increased in four of the last seven quarters, with growth averaging 16.8%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was the quarter ended Dec 31, 2025, with growth of 49.9%; the weakest was the quarter ended Sep 30, 2022, with a decline of 32.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.31 Bn |
| Mar 31, 2026 | 113.86 Bn |
| Dec 31, 2025 | 100.72 Bn |
| Sep 30, 2025 | 88.11 Bn |
| Jun 30, 2025 | 77.42 Bn |
| Mar 31, 2025 | 77.29 Bn |
| Dec 31, 2024 | 67.21 Bn |
| Sep 30, 2024 | 83.25 Bn |
| Jun 30, 2024 | 78.48 Bn |
| Mar 31, 2024 | 88.09 Bn |
| Dec 31, 2023 | 75.52 Bn |
| Sep 30, 2023 | 73.38 Bn |
| Jun 30, 2023 | 72.09 Bn |
| Mar 31, 2023 | 72.49 Bn |
| Dec 31, 2022 | 70.72 Bn |
| Sep 30, 2022 | 58.57 Bn |
| Jun 30, 2022 | 93.46 Bn |
| Mar 31, 2022 | 102.01 Bn |
| Dec 31, 2021 | 97.66 Bn |
| Sep 30, 2021 | 86.18 Bn |
API Access
Gsk Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();